5-Point-Design-Web-Development near Milner BC (4086 Result(s))

With over 30years experience working in the food industry at famous hotels and restaurants both in France and Canada, Chef Eric Arrouze now operates and manages Learn 4 Fun Consulting, a division of Carpe Diem Consulting Inc. Previously, Chef Eric worked as an executive chef at Le Cap-Estel, a 5-star hotel in Eze-bord-de-mer on the French Riviera.

CEFA offers innovative early childhood education programs designed to nurture children aged 1 to 5, emphasizing brain development and holistic growth through structured learning and child-led exploration. Their curriculum integrates language, math, problem-solving, arts, and life skills to foster confidence, independence, and a lifelong love of learning.

Anchor Branding is a full-service digital agency specializing in branding strategy, website development, animation production, and SEO. Their proven 6-step process ensures tailored solutions to drive business growth and engagement through creative strategy and tech-driven execution.

Your local, single source for business printing, direct mail, signs, displays and promo products. We also provide marketing consultation, graphic design and complete finishing and mailing services.

For many people customer service is something that’s more important than anything else. At our dealership, one thing you will get no matter what, is our respect and loyalty; and of course customer service is something that you should expect to get by default. We’re committed to serving you with quality and value. Please visit us and see what our commitment and service quality is all about! We may not be related, but you’ll feel like we’re family. So, please stop by today, and allow us to prove our loyalty and customer service to you.

We are a clinical-stage pharmaceutical company discovering and developing novel oral drug candidates to treat inflammation and cancer. Our primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Our lead product candidate, AQX-1125, has demonstrated broad anti-inflammatory activity in vitro and in vivo, and has successfully completed three clinical trials with over 100 patients enrolled to date. We are currently investigating AQX-1125 in two Phase 2 clinical trials, one for exacerbations related to Chronic Obstructive Pulmonary Disease, or COPD, and one for Bladder Pain Syndrome/Interstitial Cystitis, or BPS/IC. COPD and BPS/IC are debilitating chronic inflammatory diseases affecting millions of people worldwide.